نتائج البحث - Melih Arda Ozsoy
- يعرض 1 - 1 نتائج من 1
-
1
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses حسب Claire F. Friedman, Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula, Hunter Green, Melih Arda Ozsoy, Alexia Iasonos, Travis J. Hollmann, Mario M. Leitão, Jennifer J. Mueller, Vicky Makker, William P. Tew, Roisin E. O’Cearbhaill, Ying L. Liu, Maria M. Rubinstein, Tiffany A. Troso-Sandoval, Stuart M. Lichtman, Alison M. Schram, Chrisann Kyi, Rachel N. Grisham, Pamela Causa Andrieu, E. John Wherry, Carol Aghajanian, Britta Weigelt, Martee L. Hensley, Dmitriy Zamarin
منشور في 2024Artigo